BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanaoujiya R, Meenakshi, Srivastava S, Singh R, Mustafa G. Recent advances and application of ruthenium complexes in tumor malignancy. Materials Today: Proceedings 2022. [DOI: 10.1016/j.matpr.2022.07.098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Shereef HA, Moemen YS, Elshami FI, El-nahas AM, Shaban SY, van Eldik R. DNA Binding and Cleavage, Stopped-Flow Kinetic, Mechanistic, and Molecular Docking Studies of Cationic Ruthenium(II) Nitrosyl Complexes Containing “NS4” Core. Molecules 2023;28:3028. [DOI: 10.3390/molecules28073028] [Reference Citation Analysis]
2 Matlou ML, Louis H, Charlie DE, Agwamba EC, Amodu IO, Tembu VJ, Manicum AE. Anticancer Activities of Re(I) Tricarbonyl and Its Imidazole-Based Ligands: Insight from a Theoretical Approach. ACS Omega 2023. [DOI: 10.1021/acsomega.2c07779] [Reference Citation Analysis]
3 Kanaoujiya R, Saroj SK, Rajput VD, Alimuddin, Srivastava S, Minkina T, Igwegbe CA, Singh M, Kumar A. Emerging application of nanotechnology for mankind. Emergent Mater 2023;:1-14. [PMID: 36743193 DOI: 10.1007/s42247-023-00461-8] [Reference Citation Analysis]
4 Khatkar S, Dubey SK, Saraf P, Bhardwaj JK, Kumar S, Kumar V, Singh G, Shayoraj. Ruthenium(II) dimethyl sulphoxide based complexes: A potent inducer of apoptosis. Results in Chemistry 2022;4:100481. [DOI: 10.1016/j.rechem.2022.100481] [Reference Citation Analysis]